MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Insulet’s Q4 losses widen but 2010 losses fall 16 percent
Insulet Corp. (NSDQ:PODD) reported net losses of $20.9 million, or 50 cents per diluted share, on sales of $27.8 million during the three months ended Dec. 31, 2010. That compares with net losses of $15.5 million, or 44 cents per diluted share, on sales of $20.2 million during the same period in 2009.
Full-year losses were $61.2 million, or $1.54 per diluted share, on sales of $97.0 million. That compares with losses of $72.3 million, or $2.43 per diluted share, on sales of $66.0 million in 2009.
Read more
Masimo’s Q4 and 2010 sales, earnings rise
Masimo Corp. (NSDQ:MASI) reported profits of $16.1 million, or 26 cents per diluted share, on sales of $105.6 million during the three months ended Jan. 1. That compares with profits of $14.1 million, or 23 cents per diluted share, on sales of $92.6 million during the same period in 2009.
Full-year profits were $73.5 million, or $1.21 per diluted share, on sales of $405.4 million. That compares with profits of $53.2 million, or 88 cents per diluted share, on sales of $349.1 million in 2009.
Read more
ArthroCare posts strong Q4 results, slips to 2010 black
ArthroCare Corp. (NSDQ:ARTC) reported profits of $10.1 million, or 30 cents per diluted share, on sales of $92.6 million during the three months ended Dec. 31, 2010. That compares with profits of $7.1 million, or 21 cents per diluted share, on sales of $91.0 million during the same period in 2009.
Full-year profits were $33.8 million, or $1.02 per diluted share, on sales of $355.4 million. That compares with losses of $33.8 million, or $1.26 per diluted share, on sales of $324.1 million in 2009.
Read more
DJO Inc.’s Q4 sales slide
DJO Inc. reported losses of $10.5 million on sales of $249.8 million during the three months ended Dec. 31, 2010. That compares with losses of $11.7 million on sales of $257.2 million during the same period in 2009.
Full-year losses were $51.6 million on sales of $966.0 million. That compares with losses of $50.4 million on sales of $946.1 million in 2009.
Read more
Unilife’s Q2 sales slip, earnings slide
Unilife Corp. (NSDQ:UNIS) reported losses of $10.4 million, or 19 cents per diluted share, on sales of $1.8 million during the three months ended Dec. 31, 2010. That compares with losses of $5.9 million, or 13 cents per diluted share, on sales of $3.2 million during the same period in 2009.
Read more
Orthofix reports Q4 slide, 2010 gain
Orthofix International NV (NSDQ:OFIX) reported profits of $8.0 million, or 44 cents per diluted share, on sales of $143.8 million during the three months ended Dec. 31, 2010. That compares with profits of $9.5 million, or 55 cents per diluted share, on sales of $144.0 million during the same period in 2009.
Full-year profits were $44.2 million, or $2.47 per diluted share, on sales of $564.4 million. That compares with profits of $24.5 million, or $1.42 per diluted share, on sales of $545.6 million in 2009.
Read more
Exact Sciences reports Q4 slide, 2010 gain
Exact Sciences Corp. (NSDQ:EXAS) reported losses of $3.6 million, or 8 cents per diluted share, on sales of $1.4 million during the three months ended Dec. 31, 2010. That compares with losses of $1.9 million, or 5 cents per diluted share, on sales of $1.2 million during the same period in 2009.
Full-year losses were $11.6 million, or 29 cents per diluted share, on sales of $5.3 million. That compares with losses of $9.1 million, or 28 cents per diluted share, on sales of $4.8 million in 2009.
Read more
American Medical Systems Q4, annual profits rise
American Medical Systems Holdings Inc. (NSDQ:AMMD) reported profits of $27.2 million, or 35 cents per diluted share, on sales of $147.0 million during the three months ended Jan. 1, 2011. That compares with profits of $22.3 million, or 30 cents per diluted share, on sales of $146.0 million during the same period in 2009.
Full-year profits were $87.0 million, or $1.12 per diluted share, on sales of $542.3 million. That compares with profits of $84.8 million, or $1.14 per diluted share, on sales of $519.3 million in 2009.
Read more
Theragenics Q4, annual profits dip
Theragenics Corp. (NYSE:TGX) reported profits of $373,000, or 1 cent per diluted share, on sales of $20.3 million during the three months ended Dec. 31. That compares with profits $398,000, or 1 cent per diluted share, on sales of $18.4 million during the same period last year.
Full-year profits were $2.1 million, or 6 cents per diluted share, on sales of $80.7 million. That compares with profits of $3.1 million, or 9 cents per diluted share, on sales of $77.2 million in 2009.
Read more
Gen-Probe sees profit increase, announces share buyback
Gen-Probe Inc. (NSDQ:GPRO) reported profits of $27.2 million, or 56 cents per diluted share, on sales of $131.1 million during the three months ended Dec. 31. That compares with profits of $24.0 million, or 48 cents per diluted share, on revenue of $135.5 million during the same period last year.
Full-year profits were $106.9 million, or $2.18 per diluted share, on sales of $522.7 million. That compares with profits of $91.8 million, or $1.79 per diluted share, on sales of $483.8 million in 2009. The company yesterday announced plans to repurchase $150 million in common stock over the next year.
Read more
AdvanSource Biomaterials reports more Q3 losses
AdvanSource Biomaterials Corp. (NSDQ:ASNB) reported a loss of $803,000, or 4 cents per diluted share, on revenue of $427,000 during the three months ended Dec. 31. That compares with a loss of $542,000, or 3 cents per diluted share, on revenue of $668,000 during the same period last year.
Read more
IsoRay sees Q2 losses diminish greatly, but sales fall
IsoRay Inc. (AMEX:ISR) reported a loss of $228,069, or 1 cent per diluted share, on sales of $1.2 million during the three months ended Dec. 31. That compares with a loss of $949,867, or 4 cents per diluted share, on sales of $1.4 million during the same period last year.
Read more
Corgenix Q2 losses ease, but sales fall
Corgenix Medical Corp. (OTC:CONX) recorded a loss of about $62,000, or less than 1 cent per diluted share, on sales of $1.8 million during the three months ended Dec. 31. That compares with a loss of about $84,000, or less than 1 cent per diluted share, on sales of $2.0 million during the same period last year.
Read more
Dynatronics Q2 earnings fall after slight sales decrease
Dynatronics Corp. (NSDQ:DYNT) reported net earnings of $67,839 or 1 cent per diluted share, on sales of $8.2 million during the three months ended Dec. 31. That compares with net earnings of $188,299, or 1 cent per diluted share, on sales of $8.5 million during the same period last year. Dynatronic’s board today authorized the company to buy back up to $1 million worth of common stock.
Read more
